Insights

Sustainable Innovation World Biotechnology's focus on reducing production costs and minimizing the carbon footprint in chemicals, fuels, pharmaceuticals, and agribusiness presents a compelling opportunity for companies seeking environmentally sustainable solutions and green chemistry collaborators.

Advanced Tech Platform Utilizing cloud infrastructure such as AWS and Google Cloud, along with proprietary methods for microbial efficiency, signals a company with cutting-edge technological capabilities ideal for partnerships in biotech R&D and manufacturing process optimization.

Growth Potential As an early-stage firm with significant revenue potential within the biotech sector, focused on synthetic biology innovations, there are opportunities to engage with World Biotechnology for pilot projects, joint ventures, or contract manufacturing.

Market Expansion The company's commitment to cost-effective production of pharmaceuticals and biofuels aligns with rising market trends toward sustainable energy and healthcare, making it an attractive partner for investors and industry players aiming to enhance their green portfolio.

Funding & Strategic Position While specific funding data is not available, the company's revenue range suggests a growing and promising enterprise. Engaging with them could support early-stage investment, grants, or strategic alliances to accelerate their technological development and commercial deployment.

NA Tech Stack

NA uses 5 technology products and services including Amazon Web Services, Google Fonts API, jQuery, and more. Explore NA's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Google Analytics
    Web Analytics
  • Nginx
    Web Servers

Media & News

NA's Email Address Formats

NA uses at least 1 format(s):
NA Email FormatsExamplePercentage
First.Last@worldbiotechnology.coJohn.Doe@worldbiotechnology.co
35%
First@worldbiotechnology.coJohn@worldbiotechnology.co
15%
First.Last@worldbiotechnology.coJohn.Doe@worldbiotechnology.co
35%
First@worldbiotechnology.coJohn@worldbiotechnology.co
15%

Frequently Asked Questions

What is NA's stock symbol?

Minus sign iconPlus sign icon
NA is a publicly traded company; the company's stock symbol is NAZ.

What is NA's official website and social media links?

Minus sign iconPlus sign icon
NA's official website is worldbiotechnology.co and has social profiles on LinkedIn.

What is NA's SIC code NAICS code?

Minus sign iconPlus sign icon
NA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NA have currently?

Minus sign iconPlus sign icon
As of September 2025, NA has approximately 83 employees across 6 continents, including AsiaNorth AmericaAfrica. Key team members include Organization Manager: R. S.Data Entry Operator, Data Clerical: B. N.Author: D. C.. Explore NA's employee directory with LeadIQ.

What industry does NA belong to?

Minus sign iconPlus sign icon
NA operates in the Biotechnology Research industry.

What technology does NA use?

Minus sign iconPlus sign icon
NA's tech stack includes Amazon Web ServicesGoogle Fonts APIjQueryGoogle AnalyticsNginx.

What is NA's email format?

Minus sign iconPlus sign icon
NA's email format typically follows the pattern of First.Last@worldbiotechnology.co. Find more NA email formats with LeadIQ.

When was NA founded?

Minus sign iconPlus sign icon
NA was founded in 2013.
NA

NA

Biotechnology Research51-200 Employees

World Biotechnology is an early stage synthetic biology company that will
lower the cost of production in chemicals, fuels, pharmaceuticals,
nutraceuticals, and agribusiness, and reduce the carbon footprint along the
way. WB has developed a proprietary method to enable microorganisms to
be significantly more efficient in the production of products such as
pharmaceuticals, glucose, oils, and biofuels.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
NAZ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $100M$250M

    NA's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    NA's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.